Just over a month ago, at the BIO virtual conference, Pfizer Commercial Director John Young said the company was not thinking of a return on investment for its rapidly developing COVID-19 vaccine. Instead, he said, “finding medical solutions to this crisis” was a Pfizer priority. But now that the company …
Read More »Pharmaceutical executives reject Trump’s offer to meet on drug prices
A White House meeting with pharmaceutical executives who President TrumpDonald John Trump Biden to pay tribute to Lewis on Capitol Hill Monday. Cotton asked for comments on slavery in criticism of the 1619 Draft Congress slated for disorderly COVID-19 talks on a tight deadline. He said it would happen Tuesday …
Read More »FDA approves Gilead’s second CAR-T cancer therapy
The Food and Drug Administration has approved an advanced treatment for mantle cell lymphoma, a rare type of cancer that affects white blood cells. The one-time therapy, done by Gilead Sciences, is marked as Tecartus. Because it is important: This is the third federal approval for a CAR-T therapy, a …
Read More »